Véronique Lecault
Net worth: 59 M $ as of 31/05/2026
Net worth: 59 M $ as of 31/05/2026
Dr. Véronique Lecault is a Vice President at Lineage Biosciences, Inc. and a Chief Operating Officer & Director at AbCellera Biologics, Inc. She is on the Board of Directors at Trianni, Inc., Channel Biologics Pty Ltd. and AbCellera Biologics, Inc. She received her undergraduate degree from the University of Ottawa and a doctorate degree from the University of British Columbia.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/04/2026 | 96,13,674 ( 3.15% ) | 59 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| ABCELLERA BIOLOGICS INC. | Founder | 08/11/2012 |
Lineage Biosciences, Inc.
Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Provides medical services | Corporate Officer/Principal | 01/01/2018 |
AbCellera Australia Pty Ltd. | Director/Board Member | 01/09/2019 |
Trianni, Inc.
Trianni, Inc. BiotechnologyHealth Technology Develops humanized monoclonal antibody platform | Director/Board Member | 01/11/2020 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Ottawa
University of Ottawa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trianni, Inc.
Trianni, Inc. BiotechnologyHealth Technology Develops humanized monoclonal antibody platform | Health Technology |
AbCellera Biologics, Inc.
AbCellera Biologics, Inc. BiotechnologyHealth Technology Discovers and develops antibody drugs & therapeutics | Health Technology |
Lineage Biosciences, Inc.
Lineage Biosciences, Inc. Hospital/Nursing ManagementHealth Services Provides medical services | Health Services |
AbCellera Australia Pty Ltd. |
Select your edition
All financial news and data tailored to specific country editions